— Know what they know.
Not Investment Advice

Financial News

Sentiment 46.2 5329 articles 2917 bullish 1267 bearish Full Index →
Esperion Therapeutics (NASDAQ:ESPR) Share Price Crosses Belo

Esperion Therapeutics (NASDAQ:ESPR) Share Price Crosses Below 200 Day Moving Average – Time to Sell?

Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has...
Assenagon Asset Management S.A. Grows Holdings in Veeva Syst

Assenagon Asset Management S.A. Grows Holdings in Veeva Systems Inc. $VEEV

Assenagon Asset Management S.A. boosted its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 89.6% during the fourth...
Assenagon Asset Management S.A. Grows Holdings in Veeva Syst

Assenagon Asset Management S.A. Grows Holdings in Veeva Systems Inc. $VEEV

Assenagon Asset Management S.A. boosted its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 89.6% during the fourth...
Assenagon Asset Management S.A. Invests $24.44 Million in In

Assenagon Asset Management S.A. Invests $24.44 Million in Inspire Medical Systems, Inc. $INSP

Assenagon Asset Management S.A. bought a new stake in Inspire Medical Systems, Inc. (NYSE:INSP – Free Report) in the 4th quarter, according to...
Assenagon Asset Management S.A. Lowers Position in Brookdale

Assenagon Asset Management S.A. Lowers Position in Brookdale Senior Living Inc. $BKD

Assenagon Asset Management S.A. lessened its holdings in shares of Brookdale Senior Living Inc. (NYSE:BKD – Free Report) by 29.9% in the fourth...
Assenagon Asset Management S.A. Has $23.27 Million Stock Hol

Assenagon Asset Management S.A. Has $23.27 Million Stock Holdings in Globus Medical, Inc. $GMED

Assenagon Asset Management S.A. raised its position in Globus Medical, Inc. (NYSE:GMED – Free Report) by 510.0% during the 4th quarter,...
Assenagon Asset Management S.A. Lowers Position in Brookdale

Assenagon Asset Management S.A. Lowers Position in Brookdale Senior Living Inc. $BKD

Assenagon Asset Management S.A. lessened its holdings in shares of Brookdale Senior Living Inc. (NYSE:BKD – Free Report) by 29.9% in the fourth...
Assenagon Asset Management S.A. Acquires 680,392 Shares of O

Assenagon Asset Management S.A. Acquires 680,392 Shares of Organogenesis $ORGO

Assenagon Asset Management S.A. raised its stake in shares of Organogenesis (NASDAQ:ORGO – Free Report) by 14.0% during the fourth quarter,...
Assenagon Asset Management S.A. Grows Position in Disc Medic

Assenagon Asset Management S.A. Grows Position in Disc Medicine, Inc. $IRON

Assenagon Asset Management S.A. boosted its position in Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 3,329.8% during the 4th quarter,...
Collegium Pharmaceutical, Inc. $COLL Shares Bought by Assena

Collegium Pharmaceutical, Inc. $COLL Shares Bought by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. lifted its position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 161.6% in the...
Assenagon Asset Management S.A. Increases Position in Vaxcyt

Assenagon Asset Management S.A. Increases Position in Vaxcyte, Inc. $PCVX

Assenagon Asset Management S.A. increased its holdings in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 147.7% during the 4th quarter, according...
Assenagon Asset Management S.A. Has $30.12 Million Stock Hol

Assenagon Asset Management S.A. Has $30.12 Million Stock Holdings in Align Technology, Inc. $ALGN

Assenagon Asset Management S.A. boosted its position in Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 54.8% in the fourth quarter,...
Assenagon Asset Management S.A. Has $30.12 Million Stock Hol

Assenagon Asset Management S.A. Has $30.12 Million Stock Holdings in Align Technology, Inc. $ALGN

Assenagon Asset Management S.A. boosted its position in Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 54.8% in the fourth quarter,...
Advanced Medical Solutions Group (LON:AMS) Shares Cross Belo

Advanced Medical Solutions Group (LON:AMS) Shares Cross Below 200 Day Moving Average – Here’s What Happened

Advanced Medical Solutions Group plc (LON:AMS – Get Free Report)’s share price passed below its 200-day moving average during trading on...
WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) Short Interest Down 61

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) Short Interest Down 61.0% in March

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) was the target of a large drop in short interest in the month of March. As of March...
Assenagon Asset Management S.A. Grows Stock Position in iRhy

Assenagon Asset Management S.A. Grows Stock Position in iRhythm Technologies $IRTC

Assenagon Asset Management S.A. grew its stake in iRhythm Technologies (NASDAQ:IRTC – Free Report) by 189.2% in the 4th quarter, according to...
Assenagon Asset Management S.A. Boosts Position in Stoke The

Assenagon Asset Management S.A. Boosts Position in Stoke Therapeutics, Inc. $STOK

Assenagon Asset Management S.A. boosted its holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) by 36.4% in the fourth quarter,...
Johnson & Johnson $JNJ Shares Sold by Assenagon Asset Manage

Johnson & Johnson $JNJ Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. cut its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 69.2% in the fourth quarter, according to...
Johnson & Johnson $JNJ Shares Sold by Assenagon Asset Manage

Johnson & Johnson $JNJ Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. cut its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 69.2% in the fourth quarter, according to...
Alignment Healthcare, Inc. $ALHC Shares Acquired by Assenago

Alignment Healthcare, Inc. $ALHC Shares Acquired by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. boosted its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC – Free Report) by 6,708.0% during the 4th quarter,...
Assenagon Asset Management S.A. Invests $26.99 Million in Ta

Assenagon Asset Management S.A. Invests $26.99 Million in Tandem Diabetes Care, Inc. $TNDM

Assenagon Asset Management S.A. purchased a new position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) during the fourth quarter,...
HCA Healthcare, Inc. $HCA Shares Sold by Assenagon Asset Man

HCA Healthcare, Inc. $HCA Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 20.2% in the fourth quarter,...
HCA Healthcare, Inc. $HCA Shares Sold by Assenagon Asset Man

HCA Healthcare, Inc. $HCA Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 20.2% in the fourth quarter,...
Assenagon Asset Management S.A. Has $26.78 Million Stake in

Assenagon Asset Management S.A. Has $26.78 Million Stake in GeneDx Holdings Corp. $WGS

Assenagon Asset Management S.A. boosted its holdings in shares of GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 1,358.7% in the fourth...
Assenagon Asset Management S.A. Has $26.78 Million Stake in

Assenagon Asset Management S.A. Has $26.78 Million Stake in GeneDx Holdings Corp. $WGS

Assenagon Asset Management S.A. boosted its holdings in shares of GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) by 1,358.7% in the fourth...
Assenagon Asset Management S.A. Has $32.78 Million Stock Pos

Assenagon Asset Management S.A. Has $32.78 Million Stock Position in Gilead Sciences, Inc. $GILD

Assenagon Asset Management S.A. lowered its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 92.3% during the fourth...
Assenagon Asset Management S.A. Has $32.78 Million Stock Pos

Assenagon Asset Management S.A. Has $32.78 Million Stock Position in Gilead Sciences, Inc. $GILD

Assenagon Asset Management S.A. lowered its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 92.3% during the fourth...
Astrazeneca Plc (NYSE:AZN) Receives Average Rating of “Moder

Astrazeneca Plc (NYSE:AZN) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Astrazeneca Plc (NYSE:AZN – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the ten...
Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO) Rece

Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO) Receives Average Recommendation of “Hold” from Brokerages

Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO – Get Free Report) has earned a consensus recommendation of “Hold”...
Emerson Radio (NYSEAMERICAN:MSN) Share Price Crosses Below T

Emerson Radio (NYSEAMERICAN:MSN) Share Price Crosses Below Two Hundred Day Moving Average – Here’s Why

Shares of Emerson Radio Corporation (NYSEAMERICAN:MSN – Get Free Report) crossed below its 200-day moving average during trading on Wednesday ....
Fonar (NASDAQ:FONR) Shares Cross Above 200-Day Moving Averag

Fonar (NASDAQ:FONR) Shares Cross Above 200-Day Moving Average – Should You Sell?

Fonar Corporation (NASDAQ:FONR – Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day...
ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving Av

ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving Average – Here’s Why

ImmuCell Corporation (NASDAQ:ICCC – Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a...
AstraZeneca (LON:AZN) Share Price Passes Above 200 Day Movin

AstraZeneca (LON:AZN) Share Price Passes Above 200 Day Moving Average – What’s Next?

AstraZeneca PLC (LON:AZN – Get Free Report) shares passed above its 200-day moving average during trading on Wednesday . The stock has a...
Sarepta Therapeutics Target of Unusually Large Options Tradi

Sarepta Therapeutics Target of Unusually Large Options Trading (NASDAQ:SRPT)

Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Investors...
Sen. Angus S. King Jr. Sells Off Shares of Eli Lilly and Com

Sen. Angus S. King Jr. Sells Off Shares of Eli Lilly and Company (NYSE:LLY)

Senator Angus S. King Jr. (Independent-Maine) recently sold shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on March 24th, the...
enGene Holdings Inc. (NASDAQ:ENGN) Receives Consensus Rating

enGene Holdings Inc. (NASDAQ:ENGN) Receives Consensus Rating of “Moderate Buy” from Analysts

enGene Holdings Inc. (NASDAQ:ENGN – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the ten ratings...
Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Recommendati

Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) have received an average rating of “Moderate Buy” from the thirteen...
QuidelOrtho Corporation (NASDAQ:QDEL) Given Average Recommen

QuidelOrtho Corporation (NASDAQ:QDEL) Given Average Recommendation of “Reduce” by Brokerages

QuidelOrtho Corporation (NASDAQ:QDEL – Get Free Report) has been given an average rating of “Reduce” by the six ratings firms that...
Encompass Health Corporation (NYSE:EHC) Receives Average Rec

Encompass Health Corporation (NYSE:EHC) Receives Average Recommendation of “Buy” from Brokerages

Shares of Encompass Health Corporation (NYSE:EHC – Get Free Report) have earned a consensus recommendation of “Buy” from the ten...
Community Health Systems, Inc. (NYSE:CYH) Receives Consensus

Community Health Systems, Inc. (NYSE:CYH) Receives Consensus Rating of “Hold” from Analysts

Shares of Community Health Systems, Inc. (NYSE:CYH – Get Free Report) have received an average recommendation of “Hold” from the...
Ross Gerber Flags Micron Technology As 'Very Good Chip Compa

Ross Gerber Flags Micron Technology As 'Very Good Chip Company': Here's Why The Analyst Loves MU Stock That Has Rallied 300%

On Wednesday, Ross Gerber, CEO of Gerber Kawasaki Wealth & Investment Management, praised Micron Technology (NASDAQ:MU). Gerber Flags Micron...
Head-To-Head Survey: Omada Health (NASDAQ:OMDA) versus Charl

Head-To-Head Survey: Omada Health (NASDAQ:OMDA) versus Charles River Laboratories International (NYSE:CRL)

Charles River Laboratories International (NYSE:CRL – Get Free Report) and Omada Health (NASDAQ:OMDA – Get Free Report) are both medical...
GC Biopharma Receives Marketing Authorization for Varicella

GC Biopharma Receives Marketing Authorization for Varicella Vaccine 'BARYCELA Inj.' in Guatemala

- First regulatory clearance in Latin America marks a strategic milestone for regional market expansion - World's first antibiotic-free manufacturing...
Vanda Pharmaceuticals (NASDAQ:VNDA) Share Price Passes Above

Vanda Pharmaceuticals (NASDAQ:VNDA) Share Price Passes Above 200-Day Moving Average – Here’s Why

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has...
Supernus Pharmaceuticals (NASDAQ:SUPN) Shares Pass Above 200

Supernus Pharmaceuticals (NASDAQ:SUPN) Shares Pass Above 200-Day Moving Average – What’s Next?

Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Get Free Report) crossed above its two hundred day moving average during trading on...
MannKind Corporation (NASDAQ:MNKD) Given Average Recommendat

MannKind Corporation (NASDAQ:MNKD) Given Average Recommendation of “Moderate Buy” by Brokerages

MannKind Corporation (NASDAQ:MNKD – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten...
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Receives

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Adaptive Biotechnologies Corporation (NASDAQ:ADPT – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine...
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Recomm

Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) have been assigned an average rating of “Hold” from the nine...
« Prev 1 2 3 4 5 6 82 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms